Soluble (s) P-selectin, sE-selectin, sL-selectin and soluble intercellular adhesion molecule-1 (sICAM-1) levels were examined by monoclonal antibody-based enzyme immunoassay on serum samples taken from nine patients with acute myocardial infarction (AMI) and eight patients with stable angina pectoris (SAP) before and after the successful percutaneous transluminal coronary angioplasty (PTCA). In patients with acute phase of AMI, the levels (mean ± SEM) of sP-selectin (110 ± 18 ng/ml) and sE-selectin (54 ± 15 ng/ml) before PTCA, were significantly higher than those in the SAP group, the values being 44 ± 27 and 21 ± 4 ng/ml (p<0.05).
Introduction
Disruption of atherosclerotic plaques, involving resultant intraluminal thrombosis, has a fundamental role in the pathogenesis of acute myocardial infarction (AMI). Inflammatory cells have been considered to playa key role in plaque disruption. 1. 2 In experimental models of AMI, the inflammatory responses observed after ischemia and reperfusion, were shown to contribute to vascular and myocardial injury Y Thus, adhesion of circulating leukocytes, platelets and endothelial cells may be essential components of these inflammatory reactions in AMI with cell adhesion molecules mediating each step of cell-cell interaction. ' The family of selectins is a group of the cell adhesion molecules, which includes P-selectin, E-selectin and Lsseleetin. All three of these proteins have an N-terminal lectinlike domain, an epidermal growth factor-like domain. a variable number of consensus repeats of a sequence found in complement regulatory proteins, a transmembrane domain, and a short cytoplasmic tail." P-selectin is present in alpha-granules of platelets and Weibel-Palade bodies of resting endothelial cells. P-selectin is rapidly expressed on the plasma membrane of platelets and endothelial cells on activation by thrombin or other mediators.?:'!" High level exposure of P-selectin on the endothelial surface has been implicated in a number of inflammatorv disorders 11.1~and is present in the endothelium overlying active atherosclerotic plaque.":' E-selectin is also a specitic product of endothelial cells that are activated by cytokines and bacterial endo-was first detined as a lymphocyte homing receptor in mice, with the monoclonal antibody MEL-14.1~A human homologue of the mouse L-selectin is found on most circulating lymphocytes, neutrophils and rnonocytes.'? These three proteins mediate the tirst step of leukocyte-endothelial cell interaction. that is the low-affinity rolling."
The intercellular adhesion molecule-I (lCAM-I) is a member of the immunoglobulin superfamily. and is expressed on a variety of cell surfaces including vascular endothelial cells, fibroblasts, epithelial cells and hematopoietic cells." Interestingly, ICAM-I expression is upregulated on the endothelial cells covering the atherosclerotic plaque.I-,. 16 .~2.~1 It is a ligand for the lymphocyte functionassociated antigen-I (LFA-I), which is found on lymphocytes, monocytes and neutrophils. LFA-I plays a key role not only in adhesion but also in transmigration of inflammatory cells. I" Pvselectin." Evselectin." Lvselectin" and ICAM-l~7 can also be found in human plasma or serum as soluble (s) circulating proteins. Raised levels of these proteins are considered to be important early markers of immune responses in inflammatory disorders, allergic reactions, transplantation and malignant diseases. 2".~~'S Blann and McCollum'" have reported that in atherosclerosis. the levels of siCAM-l are increased in patients with peripheral vascular diseases and ischemic heart disease, although the level of sE-selectin did not differ from controls. In acute coronary syndrome, increased levels of sP-selectin are found in patients with evolving AMI 40 A I and unstable angina." As far as we are aware, no studies have investigated the levels of sh-selectin. siC AM-l and sL-selectin in patients with acute coronary syndrome. Because activation of the endothelial and inflammatory cells. as well as platelets. may be important in plaque disruption, intraluminal thrombosis and in ischemia/reperfusion-induced tissue damages, we measured sP-selectin, sE-selectin, sL-selectin and sICAM-I in patients with AMI. The results were compared with those taken from a group of patients of similar age and sex distribution with stable angina pectoris (SAP), and with a comparable degree of coronary artery disease.
Methods

Patient study
AMI group
We studied nine patients with AMI: six men and three women, 29 to 79 years old (mean, 57 years). They were recruited from the coronary care unit of Shinshu University Hospital, Fukuyama Cardiovascular Hospital, Iida City Hospital or Komoro Kosei General Hospital during January to April in 1994. The definition of AMI and the entry criteria for this group are: (I) presence of typical chest pain when they arrived at hospital; (2) arrival at hospital within 6 h from the onset of chest pain; (3) presence of significant ST elevation in a standard l2-electrocardiogram; (4) elevation of creatine phosphokinase at least two times higher than upper value of normal range; (5) first episode of AMI; (6) no contraindication for cardiac catheterization; and (7) presence of informed consent for acute revascularization therapy using direct percutaneous transluminal coronary angioplasty (PTCA). The mean interval between the onset of AMI, denoted by chest pain, and the urgent cardiac catheterization was 4.6 h. All patients had coronary angiography and responded successfully to coronary reperfusion (TIMI grade 0-3) by PTCA using percutaneous transluminal balloon angioplasty (PTBA). Their infarct related arteries were four left anterior descending, one left circumflex and four right coronary arteries.
SAP group
We studied eight patients with SAP: four men and four women, 42 to 72 years old (mean, 64 years). Five patients had an episode of previous myocardial infarction at least 6 months before entry into this study. They had successful elective PTCA, four PTBA, three directional coronary atherectomy (DCA) and one stent at Shinshu University Hospital or Fukuyama Cardiovascular Hospital during the same period that the AMI group was recruited.
All patients of both groups were heparinized for the coronary intervention and had intravenous infusion of nitrates during the time that blood was sampled for the soluble adhesion molecules.
Patients who had congestive heart failure. malignant arrhythmia. infectious disease or history of malignancy or connective tissue diseases were excluded from this study. Informed consent for interventional catheterization and blood sampling was obtained from each patient.
Blood sampling
In both the AMI and the SAP groups, the venous blood samples were collected before coronary angiography, just after the end of successful angioplasty and 12 hours after the PTCA, respectively. Blood was collected from femoral Vascular Medicine 1997; 2: 163-168 vein sheaths before and after PTCA, but the 12-h samples were drawn from arm veins. The blood was allowed to clot at room temperature for a minimum of I h and the serum was withdrawn following centrifugation for 10 min at 3000 rpm. The serum was then stored at -80°C until assayed. Serum cholesterol and triglyceride were measured by enzymatic method 43.44 using fasting blood samples.
Detection of soluble selectins and ICAM·1
The serum levels of sP-selectin,24 sE-selectin 25 and sL-selectin" were estimated by enzyme immunoassay using monoclonal antibodies-based Bender MedSystems ELISA kits (Bender, Vienna, Austria). The serum levels of sICAM-1 37 were measured by the CELLFREE® ICAM-I TEST KIT (T cell Diagnostics, Cambridge, MA. USA).
All 96-well plates were coated with the murine monoclonal antibodies to human P-selectin, Evselectin, L-selectin or ICAM-I. Diluted samples and standards were tested in duplicate. Horseradish peroxidase-conjugated murine monoclonal antibody to each human adhesion molecule was then added and the plates incubated for 2 h at room temperature. After PBS washing. a tetramethyl-benzidine solution was added to the selectins' plates and an o-phenylenediamine solution was added to the ICAM-I plate, respectively, as substrates. After a further 20 min of incubation, the reaction was stopped by the addition of sulfuric acid and the absorbance at 450 nm (for the selectins) or 490 nm (for the ICAM-I) was measured in a microplate reader (Corona MTP-22, Corona Electric, Japan). Standard curve was obtained by plotting the mean absorbance for each standard concentration and the concentration of soluble adhesion molecules was obtained for each sample using this standard curve. The values are expressed as mean ± SEM nglml.
Statistics
The clinical parameters from the two groups of patients studied (Table I) 
Results
Clinical characteristics
The clinical characteristics of the AMI and the SAP groups used in this study are summarized in Table I 
Serum levels of soluble selectins and (CAM·1 in AMI and SAP
The levels of sP-selectin, sE-selectin, sL-selectin and sICAM-l from the AMI and the SAP groups are shown in Figure I . Before recanalization, the mean serum levels of sP-selectin and sE-selectin in the AMI group were signifi-Soluble selectins ill ischemic heart disease 165 vation of endothelial cells, platelets or leukocytes.P:" These adhesion molecules have been shown to be expressed on the endothelial cells covering atherosclerotic plaques. J]-17. 22 .2J In the present study, we report a significant elevation of serum sP-selectin and sE-selectin levels in patients with AMI, before revascularization therapy with PTCA compared with patients with SAP. In the case of sL-selectin, there is an increase in AMI patients. but not in SAP patients. On the other hand. no significant change was found following the concentration of sICAM-l in both groups of patients.
Discussion
In acute coronary syndrome, increased levels of sP-selectin have been documented in patients with evolving AMI-wAI and unstable angina." P-selectin is present in alpha-granules of platelets and Weibel-Palade bodies of resting endothelial cells. Our finding of increased sP-selectin in AMI patients are thus in agreement with these prior observations. We also believe that the sP-selectin originates from the endothelial cells as well as platelets in the infarct. P-selectin is rapidly expressed and upregulated on the plasma membrane of platelets and endothelial cells on activation by thrombin or other mediators."!" Our finding that the sP-selectin levels are persistently elevated immediately following and 12 hours after reperfusion therapy thus reflects the activation of endothelial cells and platelets by thrombin and other inflammatory cytokines produced by this procedure. The present observation of increased sEselectin levels in AMI patients compared with SAP patients similarly reflects the activation of endothelial cells as a result of the infarction. In contrast to sP-selectin. the levels of sli-selectin progressively falls following PTCA. Published in vitro experiments show that the mRNA transcription of E-selectin induced by Il-I or TNFa on endothelial cells is short-lived for only 2-4 hours.P-" It is therefore possible that following the correction of the myocardial ischemia by PTCA, the stimulus for expression of E-selectin by endothelial cells has ceased, resulting in the progressive fall of the circulating sE-selectin levels.
[CAM-I, an adhesion molecule expressed on activated endothelial cells, is upregulated upon stimulation by cytokines, including TNFa and IL-I~. In the present study, no changes in the levels of siCAM-I were observed in the AMI group compared with those of the SAP group. ICAM-I has also been found to be constitutively expressed on the endothelial cells. macrophages, fibroblasts. epithelial cells and lymphocytes." Some of these cells are involved in the progression of atherosclerosis. Blann and McCollum- 19 reported an increased level of sICAM-1 in patients with atherosclerotic stenosis or obstruction of the carotid, iliac or femoral arteries, or abdominal aortic aneurysm and in survivors of myocardial infarction, whose venepuncture was performed at least 6 weeks after discharge from hospital. In contrast to Blann's study, the blood samples we studied were taken from patients with early AMI onset. Our results therefore suggest that siCAM-I may not be the specific marker of acute activated or injured endothelial cells.
It is known that patients with marked elevated levels of total cholesterol had increased levels of sICAM-l and sEselectin.:" In the present study. serum cholesterol level was somewhat higher in AMI patients compared with the SAP group. Since this difference is not statistically significant and in fact is smaller than the above published report." we believe that it has no influence on the levels of soluble Figure IA and IB). Although the levels of sl.-selectin in the AMI group were increased (1104 ± 106 ng/ml), these values just failed to reach significance (p = 0.08) when compared to that of the SAP group (884 ± 83 ng/ml, Figure IC) . The sICAM-I levels in the AMI group (240 ± 24 ng/rnl) did not differ from those of the SAP group (288 ± 21 ng/ml, Figure lD ). We next analyzed the levels of soluble selectins and ICAM-I in AMI both before and just after recanalization and compared with each other. As shown in Figure I , the mean sE-selectin levels were decreased from 54 ± 15 nglml to 42 ± II ng/ml. Likewise, the sl.-selectin levels were decreased from 1104 ± 106 nglml to 891 ± 59 ng/ml. Values for both sE-selectin and sl.vselectin were significantly different (P<0.05) from those obtained just after recanalization. Interestingly. neither sP-selectin nor the sICAM-I levels were significantly different before or just after reperfusion therapy. the values ranging from I 10 ± 18 ng/ml to 96 ± 21 ng/ml and from 240 ± 24 nglml to 237 ± 38 ng/ml, respectively. Moreover neither the soluble selectins nor the sICAM-I levels were significantly different just after or 12 h after reperfusion therapy.
The serum levels of sP-selectin, sE-selectin, sl.-selectin and ICAM-I measured before, just after and 12 h after elective PTCA in the SAP group are also shown in Figure I adhesion molecules. Serum level of soluble adhesion molecules is presumably determined not only by their synthesis and shedding, but also by their clearance. However, little is known about the clearance of soluble selectins and ICAM-I. The possibility remains that the marked depression of cardiac output has an influence on the clearance of these soluble molecules.
Neutrophils have been shown to mediate coronary vascular and myocardial injury after ischemia and reperfusion.:' The initial interaction between neutrophils and endothelial cells is characterized by neutrophil 'rolling' along the endothelium. L-selectin, expressed on neutrophils, P-selectin, and E-selectin mediate this rolling.'? When neutrophils are activated, L-selectin is rapidly shed from the cell surface by proteolytic cleavage occurring near the transmembrane portion." This shedding from the neutrophil surface, is coincident with the engagement of CD 18-dependent mechanisms leading to transendothelial migration." The increase seen in the sL-selectin levels in sera of AMI patients just failed to reach significance at p =0.08. compared with the SAP group. However. it is not known whether, using coronary sinus blood samples instead, there is a significant change between the AMI and SAP groups.
The comparison of soluble selectins and ICAM-I levels before and after reperfusion therapy in patients with AMI, demonstrated that sE-selectin and sL-selectin levels were significantly decreased after reperfusion therapy. In contrast, there was no significant change between before and after coronary reperfusion in sP-selectin and sICAM-1 levels. Schleiffenbaum et aJ26 reported that sL-selectin semipuritied from plasma, inhibited L-selectin-mediated lymphocyte attachment at suboptimal levels of ligand expression on TNF-activated endothelium in a dose-dependent manner. Therefore, it has been proposed that high levels of relatively low avidity sl.-selectin, circulating in plasma, might serve as a biological adhesion buffer system to prevent the attachment of leukocytes at sites where low level upregularion of the L-selectin ligand has occurred on endothelial cells. Thus. the possibility exists that decreased sL-selectin levels observed after coronary reperfusion in patients with AMI, might be related to the biological adhesion buffer system. Although the sE-selectin's function or metabolic turnover has not yet been established. we expect that sEselectin may have a function similar to sL-selectin, and possibly act as a biological adhesion buffer. If this turns out to be the case. sE-selectin might be inactivated by its binding to a ligand expressed on activated leukocytes after reperfusion therapy.
It is possible that reperfusion of an evolving myocardial infarct may reduce the release of sL-and sE-selectin. However, this cannot be determined as patients who did not have reperfusion were studied. We also have no information on whether any of the AMI patients had reocclusion in the 12 h after the procedure. Three people in the stable angina group had directional atherectomy, and one had a stent. whereas all those in the AMI group had balloon angioplasty alone. It is possible that the differences in the sLand sE-selectin levels can be accounted for by the fact that atherectomy removes a greater amount of tissue and may have different effects on the expression of these soluble molecules.
Compared to the stable angina group, sP-and sE-selectins were raised in the AMI group, whereas sL-selectin and sICAM-l were not. This might be expected as the expression of P-and E-selectin after tissue injury occur earlier than the expression of L-selectin and ICAM-I. The AMI patients may not have been followed for a long enough time to identify a higher sICAM-l or sL-selectin. Alternatively, the reperfusion of the coronary artery may have delayed or prevented the expression of IeAM-1 on the endothelial surface, or prevented the cleavage of any surface bound ICAM-I from the endothelium into the blood stream. Furthermore, it is difficult to link the expression of L-selectin with the interventional procedures that remove endothelium, as this selectin is not expressed by the endothelium. Any differences between the AMI and stable angina groups could certainly be due to the plaque rupture or thrombosis that presumably caused the myocardial infarction. However, the infarcted myocardium is a much greater stimulus for the expression of these molecules than the plaque rupture. Thus, although the soluble markers may arise from the endothelium. it is more plausible that they are the result of the inflammatory response to the infarcted tissue.
